Red Light Holland Corp. (TRUFF)
OTC Markets OTCQB
Price as at 1 Oct 2026, 02:58 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Red Light Holland Corp. trades at $0.02. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Red Light Holland Corp.
Rhelion Life Sciences Corp. engages in the research and development of psychedelic drug in Netherlands, Canada, and the United States. Its products also include PEX010, a natural psilocybin drug candidate. It also engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe, as well as selection, distribution, and export of truffles. The company was formerly known as Red Light Holland Corp. and changed its name to Rhelion Life Sciences Corp. in August 2026. Rhelion Life Sciences Corp. is based in Toronto, Canada.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its TRUFF data?
Fundamentals for TRUFF come from company filings and exchange data, as listed on OTC Markets OTCQB; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 02:58 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for TRUFF, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.
